Last reviewed · How we verify

NCT06300606: NOL and LRA

Nociception Index Level (NOL) Perioperative Monitoring During Regional Anesthesia

Status unknown Last updated 8 March 2024
What this trial tests

trial testing NOL monitoring in Regional Anesthesia in 25 participants. Status unknown.

Timeline
5 March 2024
Primary endpoint
15 April 2024
15 April 2024

Quick facts

Lead sponsorAmerican Hospital of Paris
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment25
Start date5 March 2024
Primary completion15 April 2024
Estimated completion15 April 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

American Hospital of Paris

Who can join

18 and older, any sex, with Regional Anesthesia or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective observational study was conducted to assess pain using NOL index under locoregional anesthesia for orthopedic surgery of the upper limb. We included 50 consecutive adult patients scheduled for orthopedic surgery of the upper limb under locoregional anesthesia. The locoregional anesthesia was performed under ultrasound, with or without neurostimulation. Intraoperative pain is assessed using NOL index monitoring, ALGISCORE and Numerical Scale, and second point study is the midazolam and propofol requirement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Regional Anesthesia

Currently open trials in the same condition.

Other American Hospital of Paris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06300606.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing